Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 1 minute read Healthcare Industry News BaroPace gets CDSCO approval for RelieveHFpEF-II clinical trial in India BaroPace Inc., a medical technology company focused on developing pacemaker regulation techniques based on blood pressure, has been… byPallavi MadhirajuJuly 26, 2023